#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4476902	B	Inhibition of human neurotrypsin	Homo sapiens	142	ALA4476865	single protein format	Patent Bioactivity Data
2.	ALA4476903	B	Inhibition of hog trypsin assessed as reduction in liberation of free para-nitroanilide using S-2222 substrate incubated for 20 to 30 mins	Sus scrofa	1	ALA4476865	assay format	Patent Bioactivity Data
3.	ALA4476904	B	Inhibition of human thrombin assessed as reduction in liberation of free para-nitroanilide using S-2266 substrate incubated for 20 to 30 mins	Homo sapiens	1	ALA4476865	single protein format	Patent Bioactivity Data
4.	ALA4476905	B	Inhibition of human plasmin assessed as reduction in liberation of free para-nitroanilide using S-2288 substrate incubated for 20 to 30 mins	Homo sapiens	1	ALA4476865	single protein format	Patent Bioactivity Data
5.	ALA4476906	B	Inhibition of human kallikrein assessed as reduction in liberation of free para-nitroanilide using S-2288 substrate incubated for 20 to 30 mins	Homo sapiens	1	ALA4476865	single protein format	Patent Bioactivity Data
6.	ALA4476907	B	Inhibition of human tPA assessed as reduction in liberation of free para-nitroanilide using S-2288 substrate incubated for 20 to 30 mins	Homo sapiens	1	ALA4476865	single protein format	Patent Bioactivity Data
7.	ALA4476908	B	Inhibition of human uPA assessed as reduction in liberation of free para-nitroanilide using S-2288 substrate incubated for 20 to 30 mins	Homo sapiens	1	ALA4476865	single protein format	Patent Bioactivity Data
8.	ALA4476909	B	Inhibition of human factor 10a assessed as reduction in liberation of free para-nitroanilide using S-2288 substrate incubated for 20 to 30 mins	Homo sapiens	1	ALA4476865	single protein format	Patent Bioactivity Data
9.	ALA4476910	T	Toxicity in C57/BL6 mouse assessed as weight loss dosed 3 times at 25 mg/kg, ip equivalent of active ingredient administered with 8 hrs gap between dose 1 and dose 2 and 16 hrs gap between dose 2 and dose 3 (Rvb = 5.67%)	Mus musculus	1	ALA4476865	organism-based format	Patent Bioactivity Data
10.	ALA4476911	F	Reduction in serum CAF levels in C57/BL6 mouse assessed as serum CAF levels dosed 3 times at 25 mg/kg, ip equivalent of active ingredient administered with 8 hrs gap between dose 1 and dose 2 and 16 hrs gap between dose 2 and dose 3 by Western blotting analysis (Rvb = 100%)	Mus musculus	1	ALA4476865	organism-based format	Patent Bioactivity Data